Status:
UNKNOWN
Cohort Study of Clinical Outcomes in Chronic HBV Infection Patients With Low HBsAg Under Unplanned Intervention
Lead Sponsor:
Beijing Ditan Hospital
Conditions:
Chronic Hepatitis B Infection
Eligibility:
All Genders
20-70 years
Brief Summary
All chronic hepatitis B (CHB) patients were diagnosed and treated in the liver disease department of the Hepatology Center of Beijing Ditan Hospital affiliated to Capital Medical University and those ...
Detailed Description
This study is a clinical observational cohort study. All chronic hepatitis B patients were diagnosed and treated in the liver disease department of the Hepatology Center of Beijing Ditan Hospital affi...
Eligibility Criteria
Inclusion
- Inactive carrier status and chronic hepatitis B (CHB) patients with anti-viral therapy (interferon and nucleoside analogues) reaching HBsAg \< 100 IU/ml.
Exclusion
- coinfection with other viruses including HCV, HDV, and HIV;
- syphilis antibody positive;
- co-exist other liver diseases including alcoholic liver disease, metabolic liver disease, fatty liver, drug induce liver injury, and autoimmune liver disease;
- complication of cirrhosis or liver cancer.
Key Trial Info
Start Date :
May 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2020
Estimated Enrollment :
420 Patients enrolled
Trial Details
Trial ID
NCT04030039
Start Date
May 1 2017
End Date
December 30 2020
Last Update
July 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
liver disease center, Beijing Ditan Hospital
Beijing, Beijing Municipality, China, 100015